Chongshen personal page - To The Moon

Chongshen

Chongshen

No personal profile

4Follow

3Followers

0Topic

0Badge

2021-08-30

Pfizer is still going down despite many positive news last week

Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis

2021-08-26

$NASDAQ-100 Index ETF(QQQ)$Waiting for the good time to buy in for long term investing. When is the good time to buy?

2021-08-27

$MAPLETREE LOGISTICS TRUST(M44U.SI)$Is this worth to hold

2021-08-25

$PARKWAYLIFE REIT(C2PU.SI)$ Worth to invest?

2021-09-22

$MAPLETREE LOGISTICS TRUST(M44U.SI)$Holding for long term

2021-08-26

Awesome move

2022-05-20

$MAPLETREE LOGISTICS TRUST(M44U.SI)$ hangin there

2021-12-22

$MAPLETREE LOGISTICS TRUST(M44U.SI)$Keep or lose

2021-08-20

How is Afghanistan crisis affecting the US stock market?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4091878076408990","uuid":"4091878076408990","gmtCreate":1629026475231,"gmtModify":1629032553701,"name":"Chongshen","pinyin":"chongshen","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":4,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":9021882125,"gmtCreate":1653026812967,"gmtModify":1676535211063,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a> hangin there","listText":"<a href=\"https://ttm.financial/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a> hangin there","text":"$MAPLETREE LOGISTICS TRUST(M44U.SI)$ hangin there","images":[{"img":"https://community-static.tradeup.com/news/e937a9f9aa744dac4b8ad8cb24ed4bf4","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9021882125","isVote":1,"tweetType":1,"viewCount":285,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9000661806,"gmtCreate":1640156659426,"gmtModify":1676533504149,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Keep or lose","listText":"<a href=\"https://ttm.financial/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Keep or lose","text":"$MAPLETREE LOGISTICS TRUST(M44U.SI)$Keep or lose","images":[{"img":"https://static.itradeup.com/news/0b2489b0223e2585a3c9c4dec9a4fda7","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000661806","isVote":1,"tweetType":1,"viewCount":386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":869696830,"gmtCreate":1632277223320,"gmtModify":1676530741643,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Holding for long term","listText":"<a href=\"https://laohu8.com/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Holding for long term","text":"$MAPLETREE LOGISTICS TRUST(M44U.SI)$Holding for long term","images":[{"img":"https://static.tigerbbs.com/6f66fdc653347046923bdeaa685b55c7","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869696830","isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":811297612,"gmtCreate":1630325153336,"gmtModify":1676530268707,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"Pfizer is still going down despite many positive news last week","listText":"Pfizer is still going down despite many positive news last week","text":"Pfizer is still going down despite many positive news last week","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/811297612","repostId":"2163888743","repostType":2,"repost":{"id":"2163888743","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1630320528,"share":"https://ttm.financial/m/news/2163888743?lang=&edition=fundamental","pubTime":"2021-08-30 18:48","market":"us","language":"en","title":"Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2163888743","media":"T-Reuters","summary":"Pfizer Inc :Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy O","content":"<html><body><p>Pfizer Inc <pfe.n>:Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis.Pfizer Inc - Jade Dare Trial Met Co-Primary And Key Secondary Endpoints And Demonstrated A Safety Profile Consistent With Previous Studies.Pfizer Inc - Study Showed That Abrocitinib Was Statistically Superior Compared To Dupilumab In Each Evaluated Efficacy Measure.</pfe.n></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPositive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-08-30 18:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Pfizer Inc <pfe.n>:Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis.Pfizer Inc - Jade Dare Trial Met Co-Primary And Key Secondary Endpoints And Demonstrated A Safety Profile Consistent With Previous Studies.Pfizer Inc - Study Showed That Abrocitinib Was Statistically Superior Compared To Dupilumab In Each Evaluated Efficacy Measure.</pfe.n></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LHDX":"Lucira Health, Inc.","PFE":"辉瑞","LABP":"Landos Biopharma, Inc.","CGEM":"Cullinan Therapeutics","SANA":"Sana Biotechnology, Inc.","APR":"Apria, Inc."},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2163888743","content_text":"Pfizer Inc :Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis.Pfizer Inc - Jade Dare Trial Met Co-Primary And Key Secondary Endpoints And Demonstrated A Safety Profile Consistent With Previous Studies.Pfizer Inc - Study Showed That Abrocitinib Was Statistically Superior Compared To Dupilumab In Each Evaluated Efficacy Measure.","news_type":1},"isVote":1,"tweetType":1,"viewCount":868,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819950964,"gmtCreate":1630029131658,"gmtModify":1676530204187,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Is this worth to hold","listText":"<a href=\"https://laohu8.com/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Is this worth to hold","text":"$MAPLETREE LOGISTICS TRUST(M44U.SI)$Is this worth to hold","images":[{"img":"https://static.tigerbbs.com/29b28c7d1a3f1e3ad3eb8f7ca0f0d433","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/819950964","isVote":1,"tweetType":1,"viewCount":1008,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583318222987864","authorId":"3583318222987864","name":"TheMilkyWay","avatar":"https://static.tigerbbs.com/190d59bcbcc876e15543cbd430d8c1f2","crmLevel":3,"crmLevelSwitch":1,"idStr":"3583318222987864","authorIdStr":"3583318222987864"},"content":"Personal opinion, this one worth it to hold. It has dropped to 1.92 back in May before BUT it rises at a decent rate after that by about 8% until it started falling recently.","text":"Personal opinion, this one worth it to hold. It has dropped to 1.92 back in May before BUT it rises at a decent rate after that by about 8% until it started falling recently.","html":"Personal opinion, this one worth it to hold. It has dropped to 1.92 back in May before BUT it rises at a decent rate after that by about 8% until it started falling recently."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":810078588,"gmtCreate":1629937022744,"gmtModify":1676530175886,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"Awesome move&nbsp;","listText":"Awesome move&nbsp;","text":"Awesome move","images":[{"img":"https://static.tigerbbs.com/8bcd706548fb842028691e313690d847","width":"1125","height":"3443"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810078588","isVote":1,"tweetType":1,"viewCount":474,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":837474142,"gmtCreate":1629910321986,"gmtModify":1676530170833,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QQQ\">$NASDAQ-100 Index ETF(QQQ)$</a>Waiting for the good time to buy in for long term investing. When is the good time to buy?","listText":"<a href=\"https://laohu8.com/S/QQQ\">$NASDAQ-100 Index ETF(QQQ)$</a>Waiting for the good time to buy in for long term investing. When is the good time to buy?","text":"$NASDAQ-100 Index ETF(QQQ)$Waiting for the good time to buy in for long term investing. When is the good time to buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/837474142","isVote":1,"tweetType":1,"viewCount":984,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583318222987864","authorId":"3583318222987864","name":"TheMilkyWay","avatar":"https://static.tigerbbs.com/190d59bcbcc876e15543cbd430d8c1f2","crmLevel":3,"crmLevelSwitch":1,"idStr":"3583318222987864","authorIdStr":"3583318222987864"},"content":"When buying in (aka opening a position), the general advise is to just buy in at ANY price that is NOT at the all time high & only start with a small capital. So personally, I would maybe buy in at","text":"When buying in (aka opening a position), the general advise is to just buy in at ANY price that is NOT at the all time high & only start with a small capital. So personally, I would maybe buy in at","html":"When buying in (aka opening a position), the general advise is to just buy in at ANY price that is NOT at the all time high & only start with a small capital. So personally, I would maybe buy in at"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837827879,"gmtCreate":1629876757291,"gmtModify":1676530159504,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C2PU.SI\">$PARKWAYLIFE REIT(C2PU.SI)$</a> Worth to invest?","listText":"<a href=\"https://laohu8.com/S/C2PU.SI\">$PARKWAYLIFE REIT(C2PU.SI)$</a> Worth to invest?","text":"$PARKWAYLIFE REIT(C2PU.SI)$ Worth to invest?","images":[{"img":"https://static.tigerbbs.com/758d4d61658dc03268dec7ccf99c05c4","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/837827879","isVote":1,"tweetType":1,"viewCount":726,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":838619352,"gmtCreate":1629390343476,"gmtModify":1676530027350,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"How is Afghanistan crisis affecting the US&nbsp;stock market?","listText":"How is Afghanistan crisis affecting the US&nbsp;stock market?","text":"How is Afghanistan crisis affecting the US stock market?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/838619352","isVote":1,"tweetType":1,"viewCount":441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":811297612,"gmtCreate":1630325153336,"gmtModify":1676530268707,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"Pfizer is still going down despite many positive news last week","listText":"Pfizer is still going down despite many positive news last week","text":"Pfizer is still going down despite many positive news last week","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/811297612","repostId":"2163888743","repostType":2,"repost":{"id":"2163888743","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1630320528,"share":"https://ttm.financial/m/news/2163888743?lang=&edition=fundamental","pubTime":"2021-08-30 18:48","market":"us","language":"en","title":"Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2163888743","media":"T-Reuters","summary":"Pfizer Inc :Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy O","content":"<html><body><p>Pfizer Inc <pfe.n>:Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis.Pfizer Inc - Jade Dare Trial Met Co-Primary And Key Secondary Endpoints And Demonstrated A Safety Profile Consistent With Previous Studies.Pfizer Inc - Study Showed That Abrocitinib Was Statistically Superior Compared To Dupilumab In Each Evaluated Efficacy Measure.</pfe.n></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPositive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-08-30 18:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Pfizer Inc <pfe.n>:Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis.Pfizer Inc - Jade Dare Trial Met Co-Primary And Key Secondary Endpoints And Demonstrated A Safety Profile Consistent With Previous Studies.Pfizer Inc - Study Showed That Abrocitinib Was Statistically Superior Compared To Dupilumab In Each Evaluated Efficacy Measure.</pfe.n></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LHDX":"Lucira Health, Inc.","PFE":"辉瑞","LABP":"Landos Biopharma, Inc.","CGEM":"Cullinan Therapeutics","SANA":"Sana Biotechnology, Inc.","APR":"Apria, Inc."},"source_url":"https://www.trkd.thomsonreuters.com","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2163888743","content_text":"Pfizer Inc :Positive Top-Line Results From Pfizer’S Phase 3 Jade Dare Trial Comparing The Efficacy Of Abrocitinib And Dupilumab For Moderate To Severe Atopic Dermatitis.Pfizer Inc - Jade Dare Trial Met Co-Primary And Key Secondary Endpoints And Demonstrated A Safety Profile Consistent With Previous Studies.Pfizer Inc - Study Showed That Abrocitinib Was Statistically Superior Compared To Dupilumab In Each Evaluated Efficacy Measure.","news_type":1},"isVote":1,"tweetType":1,"viewCount":868,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837474142,"gmtCreate":1629910321986,"gmtModify":1676530170833,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/QQQ\">$NASDAQ-100 Index ETF(QQQ)$</a>Waiting for the good time to buy in for long term investing. When is the good time to buy?","listText":"<a href=\"https://laohu8.com/S/QQQ\">$NASDAQ-100 Index ETF(QQQ)$</a>Waiting for the good time to buy in for long term investing. When is the good time to buy?","text":"$NASDAQ-100 Index ETF(QQQ)$Waiting for the good time to buy in for long term investing. When is the good time to buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/837474142","isVote":1,"tweetType":1,"viewCount":984,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583318222987864","authorId":"3583318222987864","name":"TheMilkyWay","avatar":"https://static.tigerbbs.com/190d59bcbcc876e15543cbd430d8c1f2","crmLevel":3,"crmLevelSwitch":1,"idStr":"3583318222987864","authorIdStr":"3583318222987864"},"content":"When buying in (aka opening a position), the general advise is to just buy in at ANY price that is NOT at the all time high & only start with a small capital. So personally, I would maybe buy in at","text":"When buying in (aka opening a position), the general advise is to just buy in at ANY price that is NOT at the all time high & only start with a small capital. So personally, I would maybe buy in at","html":"When buying in (aka opening a position), the general advise is to just buy in at ANY price that is NOT at the all time high & only start with a small capital. So personally, I would maybe buy in at"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819950964,"gmtCreate":1630029131658,"gmtModify":1676530204187,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Is this worth to hold","listText":"<a href=\"https://laohu8.com/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Is this worth to hold","text":"$MAPLETREE LOGISTICS TRUST(M44U.SI)$Is this worth to hold","images":[{"img":"https://static.tigerbbs.com/29b28c7d1a3f1e3ad3eb8f7ca0f0d433","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/819950964","isVote":1,"tweetType":1,"viewCount":1008,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583318222987864","authorId":"3583318222987864","name":"TheMilkyWay","avatar":"https://static.tigerbbs.com/190d59bcbcc876e15543cbd430d8c1f2","crmLevel":3,"crmLevelSwitch":1,"idStr":"3583318222987864","authorIdStr":"3583318222987864"},"content":"Personal opinion, this one worth it to hold. It has dropped to 1.92 back in May before BUT it rises at a decent rate after that by about 8% until it started falling recently.","text":"Personal opinion, this one worth it to hold. It has dropped to 1.92 back in May before BUT it rises at a decent rate after that by about 8% until it started falling recently.","html":"Personal opinion, this one worth it to hold. It has dropped to 1.92 back in May before BUT it rises at a decent rate after that by about 8% until it started falling recently."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":837827879,"gmtCreate":1629876757291,"gmtModify":1676530159504,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C2PU.SI\">$PARKWAYLIFE REIT(C2PU.SI)$</a> Worth to invest?","listText":"<a href=\"https://laohu8.com/S/C2PU.SI\">$PARKWAYLIFE REIT(C2PU.SI)$</a> Worth to invest?","text":"$PARKWAYLIFE REIT(C2PU.SI)$ Worth to invest?","images":[{"img":"https://static.tigerbbs.com/758d4d61658dc03268dec7ccf99c05c4","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/837827879","isVote":1,"tweetType":1,"viewCount":726,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":869696830,"gmtCreate":1632277223320,"gmtModify":1676530741643,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Holding for long term","listText":"<a href=\"https://laohu8.com/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Holding for long term","text":"$MAPLETREE LOGISTICS TRUST(M44U.SI)$Holding for long term","images":[{"img":"https://static.tigerbbs.com/6f66fdc653347046923bdeaa685b55c7","width":"1242","height":"2151"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869696830","isVote":1,"tweetType":1,"viewCount":407,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":810078588,"gmtCreate":1629937022744,"gmtModify":1676530175886,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"Awesome move&nbsp;","listText":"Awesome move&nbsp;","text":"Awesome move","images":[{"img":"https://static.tigerbbs.com/8bcd706548fb842028691e313690d847","width":"1125","height":"3443"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810078588","isVote":1,"tweetType":1,"viewCount":474,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9021882125,"gmtCreate":1653026812967,"gmtModify":1676535211063,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a> hangin there","listText":"<a href=\"https://ttm.financial/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a> hangin there","text":"$MAPLETREE LOGISTICS TRUST(M44U.SI)$ hangin there","images":[{"img":"https://community-static.tradeup.com/news/e937a9f9aa744dac4b8ad8cb24ed4bf4","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9021882125","isVote":1,"tweetType":1,"viewCount":285,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9000661806,"gmtCreate":1640156659426,"gmtModify":1676533504149,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Keep or lose","listText":"<a href=\"https://ttm.financial/S/M44U.SI\">$MAPLETREE LOGISTICS TRUST(M44U.SI)$</a>Keep or lose","text":"$MAPLETREE LOGISTICS TRUST(M44U.SI)$Keep or lose","images":[{"img":"https://static.itradeup.com/news/0b2489b0223e2585a3c9c4dec9a4fda7","width":"1242","height":"2448"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000661806","isVote":1,"tweetType":1,"viewCount":386,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":838619352,"gmtCreate":1629390343476,"gmtModify":1676530027350,"author":{"id":"4091878076408990","authorId":"4091878076408990","name":"Chongshen","avatar":"https://static.tigerbbs.com/3a1a30e4ec3afe0d900f174f9ffaa52e","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4091878076408990","authorIdStr":"4091878076408990"},"themes":[],"htmlText":"How is Afghanistan crisis affecting the US&nbsp;stock market?","listText":"How is Afghanistan crisis affecting the US&nbsp;stock market?","text":"How is Afghanistan crisis affecting the US stock market?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/838619352","isVote":1,"tweetType":1,"viewCount":441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}